ArticleCurrent microbiology2022

hsa-miR-17-5p: A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin Therapy Efficacy in Hepatitis C Infection.

Zehra Öksüz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.